d. Consensus development meeting
All stakeholders were invited to the meeting, which was attended by 24 participants in person, 6 participants virtually for the entire day, and DM in person as an advisor. The provisional statement set tabulated above was shared with the participants together with an initial draft of this manuscript. At the meeting, held in Cairo, Egypt, on the 22nd February 2022, statements that were classified as not having reached consensus in the two-round Delphi survey were individually discussed. Stakeholders decided on the agreement rate to be used as the threshold for exclusion and voted anonymously using an electronic system (Zoom meeting software) to select statements for the final set. The breakdown of statements into the various stages of the RCT research lifecycle was agreed with the stakeholder group. This included subheadings general, design and approval, conduct and monitoring, reporting of protocols and findings, post-publication concerns, and future research and development. In tabulation of the final set, the strength of evidence assessed via a modified AMSTAR-2 score26 was provided for the statements underpinned by systematic reviews.